Riversedge Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,703
| Closed | -$257K | – | 132 |
|
|
2025
Q1 | $257K | Sell |
3,703
-65
| -2% | -$4.51K | 0.06% | 98 |
|
|
2024
Q4 | $324K | Buy |
3,768
+245
| +7% | +$21.1K | 0.07% | 74 |
|
|
2024
Q3 | $419K | Sell |
3,523
-33
| -0.9% | -$3.93K | 0.1% | 59 |
|
|
2024
Q2 | $508K | Buy |
3,556
+383
| +12% | +$54.7K | 0.12% | 52 |
|
|
2024
Q1 | $407K | Buy |
3,173
+324
| +11% | +$41.6K | 0.1% | 55 |
|
|
2023
Q4 | $295K | Buy |
+2,849
| New | +$295K | 0.08% | 63 |
|